ResMed Inc.
RMD
$277.05
$3.241.18%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 4.02% | 5.93% | 10.68% | 6.54% | -2.75% |
| Total Depreciation and Amortization | 48.84% | -7.78% | 4.76% | -1.54% | 0.22% |
| Total Amortization of Deferred Charges | 1.31% | -2.22% | -0.87% | -4.52% | 0.12% |
| Total Other Non-Cash Items | -11.60% | 27.98% | 15.71% | -44.79% | 491.88% |
| Change in Net Operating Assets | -55.58% | 215.13% | -93.43% | -203.98% | 39.96% |
| Cash from Operations | -6.89% | 87.50% | -5.20% | -26.03% | 9.47% |
| Capital Expenditure | -47.07% | -0.74% | -15.72% | 28.30% | -17.41% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | -- | -- | -539.72% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 422.57% | 28.53% | -176.94% | 1,135.01% | 78.26% |
| Cash from Investing | -320.67% | 13.37% | -1,809.79% | 104.61% | -40.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | 83.33% | 90.00% | -36.36% |
| Issuance of Common Stock | 234.21% | -66.43% | 220.61% | -69.73% | 466.13% |
| Repurchase of Common Stock | -33.44% | 17.80% | -82.01% | 0.06% | -0.22% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.15% | -0.01% | 0.25% | -10.40% | -0.09% |
| Other Financing Activities | -- | -- | 100.00% | -- | -- |
| Cash from Financing | -13.75% | 2.35% | 2.14% | 61.67% | -17.08% |
| Foreign Exchange rate Adjustments | 346.73% | 127.64% | -360.18% | 8,483.72% | 102.43% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -32.63% | 329.75% | -49.16% | 41,585.14% | -98.37% |